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Abstract
Background: Today, cancer documentation is still a tedious task involving many different information systems even
within a single institution and it is rarely supported by appropriate documentation workflows.
Methods: In a comprehensive 14 step analysis we compiled diagnostic and therapeutic pathways for 13 cancer
entities using a mixed approach of document analysis, workflow analysis, expert interviews, workflow modelling
and feedback loops. These pathways were stepwise classified and categorized to create a final set of grouped
pathways and workflows including electronic documentation forms.
Results: A total of 73 workflows for the 13 entities based on 82 paper documentation forms additionally to
computer based documentation systems were compiled in a 724 page document comprising 130 figures, 94 tables
and 23 tumour classifications as well as 12 follow-up tables. Stepwise classification made it possible to derive
grouped diagnostic and therapeutic pathways for the three major classes
- solid entities with surgical therapy
- solid entities with surgical and additional therapeutic activities and
- non-solid entities.
For these classes it was possible to deduct common documentation workflows to support workflow-guided single-
source documentation.
Conclusions: Clinical documentation activities within a Comprehensive Cancer Center can likely be realized in a set
of three documentation workflows with conditional branching in a modern workflow supporting clinical
information system.
Background
Comprehensive Cancer Center documentation has con-
stituted a major effort in recent years to improve insight
into the disease itself and its progression in different pa-
tients [1–7]. Systematic documentation as a result of
such efforts has resulted in national cancer registries in
many countries [6, 7]. In addition, national cancer plans
have been established [8, 9] to collect clinical and epi-
demiological cancer data in databases such as SEER
(Surveillance, Epidemiology, and End Results Program)
of the National Cancer Institute (NCI). Efforts have been
made to standardize datasets and documentation within
those registries to support data exchange and nationwide
databases [6, 7].
In previous work several options for clinical data reuse
with requirements of cancer registry work and quality as-
surance have been described [10]. We devised a method
to split clinical data into documentation categories and
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packages which are completed in one treatment encounter
by one person. We aligned this data with the requirements
for cancer registries and quality assurance. A superset of
286 common data elements could be identified [11] which
cover clinical documentation, the baseline documentation
of German clinical cancer registries (ADT), the require-
ments for German epidemiological cancer registries
(GEKID) and the Bavarian cancer registry law (BCRL).
Several documentation scenarios have successfully been
implemented in our workflow engine, for example at the
Department of Urology [11].
But we noticed significantly different clinical docu-
mentation requirements between different depart-
ments. This forced us, for example, to modify our
schema for melanoma cases where most of the treat-
ment and follow up is carried out on outpatient basis
whereas prostate cancer is mainly treated in hospital
for many process steps.
Erlangen University Hospital (EUH), a 1361 bed
maximum-care facility, has been a certified oncology
center within the Deutsche Krebsgesellschaft since 2011.
The Comprehensive Cancer Center Erlangen-EMN
(CCC-EMN) (located at EUH, with cooperating partner
hospitals in Bamberg and Bayreuth) was founded in
2008 as one of 11 German Oncology Excellence Centers
and receives funding from Deutsche Krebshilfe e.V. One
important CCC-EMN research goal is to establish a
single-source-documentation with immediate data capture
at the clinical encounter and data reuse for quality
assurance, research and cancer registry purposes [11].
EUH runs a hospital-wide commercial Clinical Infor-
mation System (CIS) including a large variety of clinical
assessment forms and computerized physician order
entry (CPOE) functionalities, resulting in a comprehen-
sive Electronic Medical Record (EMR). The CIS supports
flexible implementation of new documentation forms
and comprises a workflow engine to govern clinical ac-
tivities using digital work lists for doctors and nurses
[12–15]. In previous activities we established hospital-
wide tumor board documentation and structured treat-
ment planning for all cancer entities [11] besides a so
called cancer diary for a fast assessment of long standing
cancer cases [4, 11]. A complete comprehensive cancer
documentation workflow to support certification and
quality control has been established in urology for pros-
tate, bladder and kidney carcinoma [11, 16].
The Erlangen clinical cancer registry associated with
EUH operates the Gießen Tumour Documentation
System (GTDS) [17, 18] cancer registry system with
some interfaces to the clinical documentation at EUH
and other regional hospitals.
We discovered that it was not possible to adapt the
mentioned implemented electronic documentation
forms and the workflow for prostate cancer at our
urology department to other cancer entities such as cer-
vical cancer, lung cancer or leukemia. In this situation
we recognized that it was essential to know which
process steps in diagnostics and therapy of all cancer en-
tities were common or similar or indeed not. Our pro-
ject was initiated in response to the fact that no global
approach could be found in literature or databases. The
goals of our study were first to make it possible to use
all medical documentation information in accordance
with single-source principles for cancer registries and
quality assurance without any additional secondary
documentation and second to implement electronic
documentation forms in our health-information system
for a large number of tumour entities.
This situation prompted the following questions:
 Is it really possible to devise one single and unified
digital documentation structure for the clinical
documentation of all cancer entities within a
Comprehensive Cancer Center?
 Is it possible to define a single and all-embracing
clinical documentation workflow from first
diagnostics to (repeated) therapy and follow-up?
 Alternatively, what is needed to adapt
documentation scenarios and documentation
workflow for the different cancer entities?
Methods
Medical specialists and expert groups focused, for their
part, on single cancer entities and devised guidelines and
clinical pathways for optimal diagnostics and treatment
[19–26]. Patient centred clinical documentation is
mandatory in most countries in paper based and elec-
tronic medical records (EMR) [27, 28]. Guidelines and
pathways interact with clinical documentation or may
even form the foundation for guideline-based clinical
documentation.
Interoperable structures such as the Cancer Biomedical
Informatics Grid (caBIG™) [5, 29, 30] have been proposed
to combine both types of documentation and to promote
a research centred interoperable biomedical informatics
infrastructure for management, analysis and dissemination
of cancer information. The topic clinical care documenta-
tion and its data reuse, however, received limited atten-
tion, within the caBIG initiative [5, 29, 30]. Thus, there is
still a considerable gap between clinical patient documen-
tation and supplementary data collection for registries,
quality assurance and research. This often results in
multiple and overlapping documentation activities on
various media [1, 31, 32].
Therefore we performed a systematic analysis and final
classification of the clinical pathways and documentation
requirements including repeated in- and outpatient
episodes and different tumour stages at the EUH for
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13 representative tumor entities, namely prostate, kidney,
bladder, colon, rectum, breast, cervical, lung (small-
cell and non-small cell lung cancer), thyroid cancer,
melanoma, plasmocytoma, acute myeloid leukemia
and lymphoma.
For this analysis we combined parts of an established
process analysis method by Pomberger and Gerken
[33–35] with semi-structured interviews, feedback
loops and classification methods in a new methodological
approach with 14 steps (Fig. 1).
According to local legislation (EUH clinical ethics
committee, http://www.ethikkomitee.med.uni-erlangen.de)
ethics approval was not needed for our study because none
of the following elements was performed:
 interviews with patients or children
 experimental tests
 animal experiments
 clinical trials in humans
 work with animal or human tissues.
Pomberger and Gerken [33, 34] described a method
which is useful for analyses designed to implement com-
puter systems in healthcare environments. We selected the
following steps, and adapted them for our own methodo-
logical purposes:
 structural analysis of diagnostics, therapy and
documentation activities connected with them
 analysis of documentation methods: paper or
computer systems or even both mixed up
 analysis of process owners
 sequence analysis of the chronological order of
process steps and
 analysis of weak points to fix and gain a unified
documentation process with computer systems
As a result we combined several popular methods,
namely process analysis and workflow modeling tech-
niques with a new focus on a great number of tumour
entities instead of single cancer entities described in pre-
vious work.
The 14 steps of the methodology comprised:
A comprehensive literature search (1) with a special
focus on expert guidelines and existing pathways for the
selected cancer entities in:
 PubMed
 ScienceDirect
 Medpilot
 Thieme eJournals
 gopubmed.com
 SpringerLink
 UpToDate Inc.
 guidelines of AWMF in Germany
(Arbeitsgemeinschaft der Wissenschaftlichen
Medizinischen Fachgesellschaften)
 medical expert literature in German language in the
field of oncology (Das Rote Buch, Kompendium
Internistische Onkologie, Therapiekonzepte
Onkologie, Pschyrembel Therapie, Taschenbuch
Onkologie 2010/2011).
Fig. 1 Methodology for the classification and grouping of oncology activities
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Data from this step was used to implement a first set of
hand-drawn workflow sketches on paper for presumed
diagnostic and treatment activities along the clinical path-
way of each cancer entity. A checklist was developed for
the semi-structured interviews with clinical cancer spe-
cialists at the EUH from all departments involved in can-
cer treatment. They were asked to answer the following
main questions (2):
 “Are the workflow graphics complete or are
important process steps missing?”
 “When does each step occur?”
 “How long does each step take?”
 “Who is responsible for each part of the process?”
 “How is the process step documented: on paper or
in computer systems?” (2).
In step (3) we conducted a first series of semi-structured
interviews with those cancer specialists participating in
the CCC-EMN activities of the respective departments.
All interview partners agreed to participate in the study.
No human material was used. No individual patient data
was integrated. Each interview took between one and two
hours for one tumour entity. Therefore at the department
of Urology one interview took between three and six
hours since three entities are part of it. As we focused on
medical decisions in diagnostics and therapy we only
interviewed experienced doctors and did not talk to
nurses. But we talked to experts for all of our electronic
information systems to gather all required content. For
each entity two interview series were performed. The ex-
perts interviewed were the same in both rounds. Globally
26 interviews were performed.
Within these interviews the typical paper based docu-
mentation forms were collected for later analysis: at our
departments still 82 paper forms additional to the
computer-based documentation systems (4).
Especially paper forms for medical history and clinical
examination processes as well as chemo- and radiotherapy
were collected and taken into account.
The process structure and setting were analyzed in
more detail by answering the following questions (5):
 “Where does each process step take place?”
 “At our hospital or outside or is even both possible?”
An overview of tasks and process owners was com-
piled in form of tables for each department and
tumour entity (6). After that a sequence of process
steps was derived in a typical chronological order (7).
This resulted in a set of draft digitized workflows (8)
which were refined based on the data from three typ-
ical patient cases selected from the digital tumour
board for each entity (9).
The workflows were designed within the software
package Microsoft Visio Professional 2010. It was se-
lected after several software tests with the workflow
modeling program solutions Visio, ARIS, Aris Express,
ADONIS and Visual Paradigm for UML. We defined
one common design with special icons to be used for all
of the 73 different workflow graphics. Furthermore, a set
of standardized symbols was drafted. This illustrated all
similar activities of the workflows, for example ultra-
sound or x-ray.
The digitized pathways and results of this stage were
fed back to the medical cancer specialists in a second
round of interviews (10) for validation to answer the
question:
 “Are the workflows complete or are important
process steps missing?”
The specialists were asked to answer the same ques-
tions mentioned above (2).
The following steps comprised finalization of the path-
ways according to the results of the feedback round (11),
stepwise comparison of entities regarding diagnostic,
therapeutic and documentation activities according to
the following question:
 “Which process steps are similar between the cancer
entities and can consequently be implemented in
electronic documentation workflow forms without
many modifications or even without any
modifications?”
The results section focuses on the classification
process (12), classification and grouping of the entities
following the goal of the step before (13) and search for
problems/potential for optimization of documentation
for all departments (14). The leading questions were:
 “What can be enhanced to help us reach our goal of
a completely digital documentation workflow?”
 “How can all medical professions be included in this
approach to improve their daily work routine?”
Results
The preparation of the interviews and the interviews
with the clinicians and other staff of the departments
themselves were performed successfully. The results sec-
tion focuses on the classification and grouping process
of the tumour entities. These parts are the most import-
ant ones to answer the prompted research questions
from the beginning.
Due to the extent and volume of the results (724 pages)
and the limited length of our paper we will describe only
the results of our classification process and what lessons
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can be learned from it for future workflow implementa-
tions at other environments.
The workflow analysis for 13 cancer entities (prostate,
kidney, bladder, colon, rectum, breast, cervical, lung
(small-cell and non-small cell lung cancer), thyroid can-
cer, melanoma, plasmocytoma, acute myeloid leukemia
and lymphoma) resulted in a total of 73 workflows for
the 13 entities. It considered 82 existing paper based
cancer documentation forms besides computer systems
in a 724 page document [16, 35].
The typical process documentation for one cancer
entity comprised between 10 and 16 pages with sep-
arate pathways and workflow diagrams for diagnos-
tics, treatment and follow-up processes. Diagnostic
pathways were for example specified down to atomic
activities such as history and clinical examination,
laboratory tests, x-ray-imaging, ultrasound imaging,
spirometry, biopsies etc.
We distinguished mandatory and optional activities,
depending on the cancer stage. For melanoma patients,
for example, a PET-CT (Positron Emission Tomography,
computer tomography) is only required in cases with a
cancer depth of more than 4 millimetres.
As a result of steps 12 and 13 described in the methods
section, the 13 entities were grouped to cancer types in
tabulated format, separately for diagnostic (see Table 1 for
a condensed version) and therapeutic activities. At this
stage, the entities colon and rectum carcinoma were
grouped together in one common cancer type with many
similarities, and plasmocytoma plus acute myeloid
leukemia were grouped in a non-solid cancer type, mainly
treated with chemotherapy and stem cell transplant.
Within this tabular presentation further classification
was done and this yielded common categories (marked
boxes in Table 1). These categories subsume similar
diagnostic workflows for the entities prostate, kidney
and bladder carcinoma respectively breast and cervical
carcinoma (Table 1).
Categories with similar process steps and activities
obtained at this stage support the assumption that
documentation activities can be implemented in common
digital forms with minor adaptions to the respective
cancer entities.
Table 2 summarizes the categorization results obtained
for the diagnostic and therapeutic workflows. Alignment
was possible among 5 entity groups with similar thera-
peutic and diagnostic activity workflows. Thyroid cancer
cases and lung cancer cases stand for themselves.
In a subsequent step we assembled condensed, top
level, grouped pathway diagrams (Fig. 2). These grouped
diagrams preserve the essential differences between the
entities, for example, no digital rectal examination in
kidney cancer cases, and computer tomography (CT)
staging for some kidney cases, due to the fact that early
kidney cancer stages can be cured by surgery, whereas
advanced stages require combinations of surgery, radi-
ation and chemotherapy, adapted to the individual pa-
tient. The potential combinations had been analysed in
advance according to the UICC (Union for International
Cancer Control) - and AJCC (American Joint Commit-
tee on Cancer) –systems. Follow-up intervals and proce-
dures were collected for all entities and arranged in
special tables.
With those grouped pathway diagrams and the process
entities included we can derive the basis for common
clinical cancer documentation on a level of sufficient
detail for subsequent use in quality assessment, certi-
fication, cancer registries, studies or other research.
A grouped pathway would correspond to a common
set of CIS documentation forms and a common docu-
mentation pathway with minor branching to accommo-
date such specific requirements as the mentioned rectal
examination or the CT staging in some of the cases.
Branching within the grouped workflow is also required
for different tumour classification schemes or different
cancer follow-up timetables in the respective entities.
It was not possible to gain only one class for all en-
tities because we realized that the prostate cancer
workflow, for example, was not transferable to melan-
oma or breast cancer since the components of the
process were too different to get only one group for
all of them. For melanoma you have other tumour
markers and incident light microscopy. For prostate
you have a digital-rectal examination for example, but
not for melanoma.
First of all we identified two main groups after finish-
ing the classification process:
 solid and
 non-solid-entities (plasmocytoma and acute myeloid
leukemia)
In a next step we realized that in early stages surgery
may be the only therapeutic component of a process
(see melanoma or kidney cancer patients) and if there
were metastases we would have combinations of surgery,
radio- and chemotherapy (see breast cancer or cervical
cancer for example).
Grouped pathway diagrams were possible for three
major classes of tumour entities (Fig. 3), namely
 Solid entities with surgical therapy comprising
prostate, kidney, bladder, cervical, colon and
lung carcinoma. Typically, therapy starts
with inpatient surgery and continues on an
ambulatory basis.
 Solid entities with surgical therapy and additional
therapeutic activities, e. g. thyroid carcinoma surgery
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Table 1 Tumour entities: comparison concerning diagnostic procedures of 13 entities at the CCC Erlangen-EMN
X: obligate steps; (X): ‘facultative’ steps; BMA bone marrow aspiration, Pro Prostate, Kid Kidney, Bla Bladder, Mel Melanoma, Col Colon, Rec Rectum, Bre Breast,
Cer Cervical cancer, Thy Thyroid, Pla Plasmocytoma, AML Acute myeloid leukaemia, Lym Lymphoma: not analysed separately, Lun Lung
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combined with inpatient radio-chemotherapy. Or
melanoma, often treated with ambulatory surgery
and outpatient follow-up.
 Non solid entities such as plasmocytoma and leukemia
typically treated initially with inpatient chemotherapy.
As a next step following the classification process we
focus on the development of corresponding unified
documentation workflows.
A total of 73 workflows for the 13 entities based on 82
paper documentation forms were compiled in a 724
page document comprising 130 figures, 94 tables and 23
tumour classifications and 12 follow-up tables.
The identified three classes should be recognized
when implementing clinical documentation modules
because they show some important differences be-
tween the entities. Furthermore, the order of inpatient
and outpatient episodes is too different that a single
clinical documentation module which would strive to
cover all three would have to support inpatient and
(cross-institutional) outpatient documentation activ-
ities alike. For example, remember melanoma cancer
with treatment mainly on ambulatory basis, compared
to leukemia mainly treated in hospital. The first and the
third class are discrepant with regard to the fact that for
the surgical entities close integration with the surgical
planning and documentation systems and bidirectional
exchange of highly structured data is required.
Outpatient data connected with the processes and pa-
tient cases is collected by a web-based application from
external or by our own hospital doctors, for example,
during the follow-up talks at our department (manual
data input into our CIS).
Construction of single source clinical cancer documen-
tation thus started as follows: For each of the three classes
we defined a common and intrinsic documentation path-
way for diagnostics, therapy and follow-up which caters
for the specific entity and tumour stage related diagnostics
and treatment options for each affected entity. These op-
tions were mirrored in conditioned branches within forms
and the workflow engine of the CIS as a guide through
the great amount of documentation forms. At any time,
the generalized pathway may be complemented with add-
itional stage and entity specific sub workflows according
to patient-specific decisions by the interdisciplinary
tumour board sessions.
To substantiate this approach we analyzed the current
data processing environment to advance the unification of
cancer documentation, e.g. for solid cancer entities. An over-
view of diagnostics and staging workflow is given in Table 3.
Five clinical departments are primarily responsible for
the treatment of the solid entities with surgical therapy
prostate, kidney, bladder, cervical, colon and lung carcin-
oma: The departments of urology, general surgery,
gynecology, pulmonology and thoracic surgery. Patients
with advanced disease however undergo primary treat-
ment in the departments of radiotherapy and oncology.
Table 3 demonstrates that, at the time of the study,
some IT applications within the CIS were already uni-
fied: E.g. the browser-based application for radiology
CPOE (W) is available in all departments. Biopsy reports
are mostly written in the same surgical department ap-
plication MCC.NET™. At the time however, radiotherapy
documentation was largely paper based (apart from
radiotherapy planning software applications and Lantis™),
indicating that there was room for improvement.
We implemented electronic documentation workflows
and documentation forms for all steps of the diagnostic
and therapeutic processes in our workflow engine of the
CIS. After this important step we evaluated the effects
on our hospital organization and the daily documenta-
tion workload of the doctors, compared to the mixed-up
documentation structures before.
To sum up the main impacts of our workflow imple-
mentation we noticed a reduced documentation time,
higher quality in the documented fields and its contents
as well as a greater database for reuse of our clinical rou-
tine data in our cancer registry after export from the CIS.
In the fields of medical history and clinical examin-
ation data quality could be improved most by replacing
all different sorts of paper forms through one single
branched electronic version for all departments. The
same effect applied to radio- and chemotherapy planning
as well as the treatment cycles.
The documentation workload of our doctors could be
reduced by nearly 25 per cent. Moreover, the satisfaction
of our doctors regarding clinical documentation itself
could be increased by our approach. But finally even the
patients profit from the greater database of structured
information at the EUH since we can easily reuse exist-
ing data for research or certification without additional
efforts to provide the best treatment options.
Table 2 Deriving groups of combined entities with similar
diagnostic or therapeutic activities
Summarized workflow categorization results after grouping to cancer types
Diagnostic classes Therapy classes
• Prostate, kidney and bladder cancer • Prostate, kidney and bladder
cancer
• Breast cancer, cervical cancer • Breast cancer, cervical cancer
• Melanoma • Melanoma
• Cancer of colon and rectum • Cancer of colon and rectum
• Lung, thyroid cancer • Lung cancer: small cell and
non-small cell lung cancer
• no corresponding diagnostic type • Thyroid cancer
• Acute myeloid leukemia,
plasmocytoma
• Acute myeloid leukemia,
plasmocytoma
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Fig. 2 Grouping of diagnosis and therapy for prostate, kidney and bladder
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Discussion
The prompted research questions from the beginning
could be answered as follows:
 Is it really possible to devise one single and unified
digital documentation structure for the clinical
documentation of all cancer entities within a
Comprehensive Cancer Center?
It is possible to cover all cancer entities with one elec-
tronic documentation workflow engine system solution.
But you need three classes of entities to deal with all
Fig. 3 Grouping tumour entities to three classes
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exceptions of the diagnostic and therapeutic processes.
One class alone would not be able to solve this
approach.
 Is it possible to define a single and all-embracing
clinical documentation workflow from first diagnostics
to (repeated) therapy and follow-up?
We stated examples from our processes to show that
this is possible for medical history, clinical examination,
laboratory, imaging techniques and biopsy as well as
surgery and radio- or chemotherapy. As a condition,
however, you need the same electronic documentation
environment/system for each step at all departments
of the hospital and adjustable electronic documentation
forms to cover differences between the entities by
branching. In addition, paper forms have to be replaced by
electronic equivalents completely.
 Alternatively, what is needed to adapt
documentation and documentation workflow for the
different cancer entities?
In the complete report of our project (724 pages) [35]
we described the details to adapt documentation
methods for the unification of all similar process steps in
diagnostic and therapy.
The first steps for a unified application are the unifica-
tion of data source systems and especially elimination of
non-digital sources. In our case, the department of
radiotherapy underwent a complete redesign of informa-
tion flow and clinical documentation, which has resulted
in digital documentation of history and examination
within the system plus digitizing and PACS (picture ar-
chiving and communication system) connection for the
planning CT to adapt for a future unified documenta-
tion. In our case study the urology department runs two
clinical information systems because it has two different
locations in the city of Erlangen.
There have, in the past, been many efforts to intro-
duce, support and standardize clinical cancer documen-
tation using single-source approaches or other thoughts
[1, 10, 11, 28, 30, 36–38]. Existing standards such as
HL7 and other specifications for data exchange between
medical service providers alone are not able to fill the
gap und to achieve a flexible and adjustable workflow-
guided tumour documentation of all medical steps at a
CCC. Current German guidelines or recommendations
in literature [39–42] are mostly text based and static and
thus, unfortunately, unable to particularly support clinical
pathways with documentation workflows [43, 44].
IT supported clinical pathways [28, 37, 45–51] are still
scarce and only few implementations have made it into
routine clinical use. In addition, many approaches did
not result in wide applicability and comprehensive data re-
use for many purposes, but concentrated on specific
needs, for example bioinformatics purposes and molecular
research in the case of the Cancer Biomedical Informatics
Grid™ (caBIG™) [5, 29, 30].
Registry based documentation systems such as GTDS
or other center focused cancer documentation systems
rarely support guidelines or workflows and demand
extra documentation activities outside the regular hos-
pital CIS for cancer cases, which limits their usability
[16, 31, 52, 53].
With regard to the methods we combined several
popular methods, namely process analysis [33, 34] and
workflow modeling techniques with a focus on a great
number of tumour entities instead of single cancer
entities described in previous work.
Table 3 Process steps in electronic documentation suitable for a unified documentation in diagnostics
Process steps in documentation suitable
for a unified documentation in diagnostics
Urology Surgery Gynecology Pulmonology/gastroenterology/
thoracic surgery
Radiotherapy Hematology/
oncology
History S/F P P P/S P P
Examination S/F P P P/S P P
Biopsy M/S/P M P M/S - S
x-raying W/F W W W W/P W
Ultrasound S/P/F Plaza V V - -
CT W/F W W W P W
MRT W W W W P W
FDG-PET/SPECT W W W W - W
Laboratory examination L L L L L L
S clinical information system, P paper based documentation
L laboratory information system, W web-based radiology application
V application for storing ultrasound pictures
M program for surgery reports
F own clinical information system of the Waldkrankenhaus St.Marien Erlangen
“-” = not used, Plaza part of our radiology information system
Wagner et al. BMC Medical Informatics and Decision Making  (2015) 15:107 Page 10 of 13
Within this paper we have devised an approach which
starts from the single-source paradigm and data reuse
for following activities. Besides, it considers the typical
CIS as the primary data source which shall be adapted
for these purposes. We combined a clinical pathway ana-
lysis and the subsequent categorization and classification
steps to obtain grouped pathway diagrams for cancer
diagnostics and treatment.
Final we came to the conclusion that
 one single static clinical documentation module will
not be sufficient to cover the documentation
requirements for all cancer entities by applying only
one class alone without branching entities to groups.
 It is however possible to construct a complete
clinical documentation workflow in a three tier
approach dependent on the tumour type.
 Within one tier, branching options of the CIS forms
and workflow engine can potentially support the
adaption to different entities and cancer stages.
Thus we hope to be able to guide clinicians with re-
stricted effort through the jungle of treatment and docu-
mentation and to promote the right documentation
activities at the right time. Our workflow model will
manage the appearance of electronic documentation
forms in our CIS for all process steps of all patients at
the EUH from initial diagnostics, treatment to follow-up.
The developed workflow model takes care of changing
and optimized or even new therapeutic standards in
radio- or chemotherapy. We provide flexible structures
for chemotherapy and radiotherapy schemes that adapt
to the patient’s individual case/stage and focus on other
conditions during treatment process. Therefore, it is easy
to integrate new therapeutic knowledge within our
workflow model.
Our goal is a structured clinical documentation net-
work for cancer cases, covering history/diagnostics, ther-
apy and follow-up activities for the different CCC-EMN
cancer entities. The CIS workflow would be activated
through either a patient diagnosis or the tumour board
decision. Then the user will be guided to the documen-
tation steps at the specific time, with reminders for “for-
gotten” activities. Many steps in the analysed pathways
are conditional, in the sense that previous diagnostic or
therapeutic activities have to be finished first. Facultative
procedures would be offered as an option depending on
individual cancer stage and patient’s characteristics.
Some steps, however, do not have a fixed order which
must be respected in the workflow engine. It does not
matter whether an ultrasonic examination is done before
or after an x-ray e. g., if both are needed for proceeding
to the next workflow steps, for example for colon/rec-
tum cancer.
The model of grouped workflows can potentially be
transferred to other environments, especially other
Comprehensive Cancer Centers, because the pathways
are originally based on expert guidelines and literature
[16]. Furthermore, they have been quality checked for
completeness and ambiguity during repeated interviews
with experienced clinical specialists.
Conclusions
The findings of this investigation may be a guideline for
other Cancer Centers on the way to workflow- based
single source cancer documentation aligned with current
diagnostics and treatment pathways. We may state that
grouped pathways for three categories of cancer diseases
in combination with a sufficiently flexible CIS should en-
able the realization of clinical cancer documentation for
all entities of a Cancer Center. It will remain an interest-
ing task for the future, however, to see how disparate
CIS in the different ambulatory and inpatient institu-
tions could be linked within such pathways. With regard
to methodological aspects this study describes a new
combined 14 step method designed to derive, categorize
and classify common, grouped clinical pathways for
cancer patients. The study confirms that such grouped
clinical pathways may be translated into documentation
modules with conditional branching. They may be realized
within the forms and workflow engine of a modern
Clinical Information System (CIS).
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